Literature DB >> 15156956

Impact of age on the outcome of liver resections.

Luca Aldrighetti1, Marcella Arru, Giliola Calori, Roberto Caterini, Laura Comotti, Giorgio Torri, Gianfranco Ferla.   

Abstract

The purpose of this study was to evaluate the influence of age on the outcome of liver resections. One hundred five consecutive hepatic resections were divided into two groups: > or = 65 years old [old group (O-group)] and < 65 years old [young group (Y-group)]. The two groups were first compared to evaluate the distribution of the variables potentially affecting the postoperative course, including primary diagnosis, concomitant diseases, previous upper abdominal surgery, type of operation (major or minor resection), associated procedures, presence and length of portal clamping, intraoperative blood losses and transfusions, and length of operation. The outcome of hepatic resections in the two groups was comparatively evaluated in terms of postoperative mortality, morbidity, transfusions, and length of postoperative hospitalization. The Y-group included 61 resections in 60 patients, mean age 52 +/- 10 years (mean +/- SD), range 23-64 years, whereas the O-group included 44 resections in 43 patients, mean age 71 +/- 4 years (mean +/- SD ), range 65-82 years. The O-group included more hepatocellular carcinomas (45.4% vs 18.0%, P = 0.002) and chronic liver diseases (40.9% vs 18.7%, P = 0.017); the median length of operation was slightly higher in the Y-group (300 minutes vs 270 minutes, P = 0.003). Both O-group and Y-group were comparable (P = n.s.) when evaluated for all other listed variables. As far as concerns the outcome of hepatic resections in the two groups, the length of postoperative hospitalization was identical (median 9 days, 5-60 days), whereas transfusions of packed red cells (O-group vs Y-group: 25.0% vs 16.3%, P = 0.30) or fresh frozen plasma (O-group vs Y-group: 13.6% vs 6.5%, P = 0.053) were not statistically different. Postoperative mortality included one case among young patients whereas no deaths were recorded among elderly patients. Postoperative morbidity was higher in Y-group than in O-group (31.5% vs 20.5%, P = 0.59). The age factor does not negatively affect the outcome of liver resections.

Entities:  

Mesh:

Year:  2004        PMID: 15156956

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

1.  Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series.

Authors:  Julie N Leal; Eran Sadot; Mithat Gonen; Stuart Lichtman; T Peter Kingham; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2016-11-30       Impact factor: 3.647

Review 2.  Impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Kenji Okita; Shigenori Ota; Masayuki Ishii; Tomomi Ueki; Toshihiko Nishidate; Yasutoshi Kimura; Tomohisa Furuhata; Koichi Hirata
Journal:  Surg Today       Date:  2014-02-14       Impact factor: 2.549

3.  Practical questions in liver metastases of colorectal cancer: general principles of treatment.

Authors:  Héctor Daniel González; Joan Figueras
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

4.  Age Does Not Affect Metoprolol's Effect on Perioperative Outcomes (From the POISE Database).

Authors:  Michael J Jacka; Gordon Guyatt; Richard Mizera; Janet Van Vlymen; Dario Ponce de Leon; Thomas Schricker; Mohd Yani Bahari; Bonan Lv; Lalitha Afzal; Maria Pilar Plou García; Xinmin Wu; Lília Nigro Maia; Maribel Arrieta; Purnima Rao-Melacini; Philip J Devereaux
Journal:  Anesth Analg       Date:  2018-04       Impact factor: 5.108

5.  Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile?

Authors:  J Figueras; E Ramos; S López-Ben; J Torras; M Albiol; L Llado; H D González; A Rafecas
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.